122 related articles for article (PubMed ID: 2552752)
21. Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver.
Nayak NC; Dhar A; Sachdeva R; Mittal A; Seth HN; Sudarsanam D; Reddy B; Wagholikar UL; Reddy CR
Int J Cancer; 1977 Nov; 20(5):643-54. PubMed ID: 72736
[No Abstract] [Full Text] [Related]
22. IgM responses to hepatitis-A virus and hepatitis-B core antigen in acute and chronic liver disease in Malawi; possible role of non-A, non-B, hepatitis.
Supran EM; Molyneux ME; Banatvala JE
Trans R Soc Trop Med Hyg; 1980; 74(3):389-92. PubMed ID: 6254219
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma.
Kaklamani E; Trichopoulos D; Tzonou A; Zavitsanos X; Koumantaki Y; Hatzakis A; Hsieh CC; Hatziyannis S
JAMA; 1991 Apr; 265(15):1974-6. PubMed ID: 1848908
[TBL] [Abstract][Full Text] [Related]
24. The role of hepatitis B virus in the etiology of hepatocellular carcinoma in Australia.
Dalgleish AG; Woods RL; Levi JA; Raghavan D; McCaughan GW; Tattersall MH
Aust N Z J Med; 1983 Dec; 13(6):605-7. PubMed ID: 6326728
[TBL] [Abstract][Full Text] [Related]
25. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
26. [Etiologic determination of chronic liver diseases].
Andreoni G; Contardi MA; Panizza P; Vegezzi C; Maggi G
Minerva Med; 1985 Oct; 76(38):1751-5. PubMed ID: 2995871
[TBL] [Abstract][Full Text] [Related]
27. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
28. [Purpuric syndrome as a precursor of acute anicteric hepatitis in a HBsAG negative patient positive for HBsAB, HBcAB and anti-HAV hepanostika].
Abbasciano V; Sighinolfi L
Clin Ter; 1988 Dec; 127(6):467-9. PubMed ID: 2854033
[No Abstract] [Full Text] [Related]
29. Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease in Nepal.
Shrestha SM; Tsuda F; Okamoto H; Tokita H; Horikita M; Tanaka T; Miyakawa Y; Mayumi M
Hepatology; 1994 Apr; 19(4):805-9. PubMed ID: 8138250
[TBL] [Abstract][Full Text] [Related]
30. HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.
Theilmann L; Gmelin K; Will H; Czygan P; Hasche G; Doerr HW; Kommerell B
Z Gastroenterol; 1984 Apr; 22(4):182-7. PubMed ID: 6328781
[TBL] [Abstract][Full Text] [Related]
31. [Expression of GST-pi and HBV infection in hepatocellular carcinoma].
Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R
Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393
[TBL] [Abstract][Full Text] [Related]
32. Seroconversion from HBs-Ag to anti-HBs in a case of liver cirrhosis associated with hepatocellular carcinoma.
Unakami M; Komiya I; Endo Y; Hara M; Ikeda K; Kumada H; Yoshiba A; Hino O; Kitagawa T
Tohoku J Exp Med; 1987 May; 152(1):81-6. PubMed ID: 3039691
[TBL] [Abstract][Full Text] [Related]
33. Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
Gasser RW; Judmaier G; Zur Nedden D; Aufschnaiter M; Hofstaedter F
Am J Gastroenterol; 1983 May; 78(5):305-8. PubMed ID: 6189392
[TBL] [Abstract][Full Text] [Related]
34. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
35. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.
d'Arville CN; Nouri-Aria KT; Johnson P; Williams R
Hepatology; 1991 Feb; 13(2):310-5. PubMed ID: 1847351
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
Zhou H; Wang H; Zhou D; Wang H; Wang Q; Zou S; Tu Q; Wu M; Hu H
Eur J Cancer; 2010 Apr; 46(6):1056-61. PubMed ID: 20202823
[TBL] [Abstract][Full Text] [Related]
37. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
38. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of HBV, HCV and HDV serum markers in patients with liver cirrhosis (LC) and hepatocellular carcinoma (HCC)].
Zeng WZ; Chu RJ; Jiang MD
Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):167-9. PubMed ID: 8222980
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
